Icotrokinra Results Show Potential to Set a New Standard of Treatment in Plaque Psoriasis
March 08, 2025
March 08, 2025
NEW BRUNSWICK, New Jersey, March 8 -- Johnson and Johnson issued the following news release:
* * *
Icotrokinra results show potential to set a new standard of treatment in plaque psoriasis
Standout combination of complete skin clearance and favorable safety profile in a once daily pill could shift treatment paradigm
Nearly half of patients with moderate-to-severe plaque psoriasis (PsO) treated with investigational icotrokinra achieved completel . . .
* * *
Icotrokinra results show potential to set a new standard of treatment in plaque psoriasis
Standout combination of complete skin clearance and favorable safety profile in a once daily pill could shift treatment paradigm
Nearly half of patients with moderate-to-severe plaque psoriasis (PsO) treated with investigational icotrokinra achieved completel . . .